We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Top Buys

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$72.6M
2
RNAM
Avidity Biosciences
RNAM
+$33.7M
3
CUTR
Cutera, Inc.
CUTR
+$31.5M
4
ACET icon
Adicet Bio
ACET
+$13M
5
RBAC
RedBall Acquisition Corp.
RBAC
+$12.4M

Top Sells

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$26.8M
2
PMVP icon
PMV Pharmaceuticals
PMVP
+$26.3M
3
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$16.9M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
GBTG icon
American Express Global Business Travel
GBTG
+$7.37M

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCOBW
626
DELISTED
ScION Tech Growth II Warrants
SCOBW
$1K ﹤0.01%
+10,000
New +$2.05K
FOXWW
627
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$1K ﹤0.01%
+14,875
New +$991
TCDA
628
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
+80
New +$761
SPTKW
629
DELISTED
SportsTek Acquisition Corp. Warrant
SPTKW
$1K ﹤0.01%
29,800
-200
-0.7% -$31
ATA.WS
630
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$1K ﹤0.01%
+20,265
New +$1.84K
TEN
631
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$1K ﹤0.01%
+13,000
New +$219K
NOACW
632
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$1K ﹤0.01%
17,467
-7,533
-30% -$853
ADRT.WS
633
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
$1K ﹤0.01%
14,500
-5,000
-26% -$515
FRGE.WS
634
DELISTED
Forge Global Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock a
FRGE.WS
$1K ﹤0.01%
+16,499
New +$20.1K
ACAD icon
635
CALL
Acadia Pharmaceuticals
ACAD
$5.06B
– –
-9,000
Closed -$14K
ACAD icon
636
PUT
Acadia Pharmaceuticals
ACAD
$5.06B
– –
-9,000
Closed -$11K
AENT icon
637
Alliance Entertainment
AENT
$288M
– –
-34,612
Closed -$342K
AFRM icon
638
CALL
Affirm
AFRM
$25.3B
– –
-20,000
Closed -$65K
ALGN icon
639
Align Technology
ALGN
$12.5B
– –
-1,131
Closed -$493K
ALNY icon
640
Alnylam Pharmaceuticals
ALNY
$29B
– –
-436
Closed -$61.9K
AMC icon
641
CALL
AMC Entertainment Holdings
AMC
$2.16B
– –
-20,000
Closed -$1.74M
ANTX icon
642
AN2 Therapeutics
ANTX
$213M
– –
-60,278
Closed -$908K
ARKK icon
643
PUT
ARK Innovation ETF
ARKK
$6.37B
– –
-1,025,000
Closed -$15.6M
BALY icon
644
Bally's
BALY
$637M
– –
-8,357
Closed -$257K
BAX icon
645
Baxter International
BAX
$14.4B
– –
-8,171
Closed -$634K
BLNK icon
646
Blink Charging
BLNK
$86.7M
– –
-55,000
Closed -$1.46M
BLNK icon
647
PUT
Blink Charging
BLNK
$86.7M
– –
-55,000
Closed -$464K
BMRN icon
648
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
– –
-37,500
Closed -$46K
BMRN icon
649
BioMarin Pharmaceuticals
BMRN
$13.3B
– –
-9,312
Closed -$718K
BMRN icon
650
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
– –
-37,500
Closed -$94K
24 25
26
27 28

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.